In my opinion, we are undervalued and hence have a high probability of seeing higher prices in the near future.
As previously mentioned, LDX have multiple functional medtech devices (with more in development), multiple distributors across multiple nations (USA, Europe, Aus, NZ), and a growing customer base. LDX also currently have ~ AUD $10 million cash in bank.
Current market cap is under AUD $20 million dollars. We hold half our market cap in cash, not to mention the value of the company, its products, and its growing customer base.
We may or may not need a catalyst, but either way, i think we have a high probability of seeing higher prices.
LDX Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
